It has been shown that the down-regulation of Epb4114aos (also known as EPB41L4A-AS1) leads to brain aging and neurodegenerative diseases by damaging the synthesis of NAD+ and ATP in the brain [30]. This evidence concerns the gene EPB41L4A and neurodegenerative disease.